Acadia Healthcare (NASDAQ:ACHC) Updates FY 2026 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.300-1.550 for the period, compared to the consensus EPS estimate of 1.470. The company issued revenue guidance of $3.4 billion-$3.5 billion, compared to the consensus revenue estimate of $3.4 billion. Acadia Healthcare also updated its Q1 2026 guidance to 0.250-0.300 EPS.

Acadia Healthcare Price Performance

Shares of Acadia Healthcare stock traded down $0.67 during trading on Thursday, reaching $27.34. The company’s stock had a trading volume of 1,981,907 shares, compared to its average volume of 3,538,870. The stock has a 50-day moving average price of $23.13 and a two-hundred day moving average price of $19.08. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a one year low of $11.43 and a one year high of $28.48. The stock has a market capitalization of $2.52 billion, a P/E ratio of -2.24, a price-to-earnings-growth ratio of 9.27 and a beta of 0.71.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million during the quarter, compared to analysts’ expectations of $800.10 million. During the same period in the previous year, the business posted $0.64 earnings per share. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare will post 1.48 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have weighed in on ACHC shares. Royal Bank Of Canada boosted their price objective on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, February 26th. UBS Group upped their price target on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. Leerink Partners upped their price target on Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research note on Thursday, February 26th. TD Cowen boosted their price objective on Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $25.00 price objective on shares of Acadia Healthcare in a research report on Thursday, February 26th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $22.19.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in Acadia Healthcare in the 1st quarter valued at $1,600,000. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 21.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after purchasing an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after purchasing an additional 88,995 shares in the last quarter. Finally, Prudential Financial Inc. grew its holdings in shares of Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after purchasing an additional 1,780 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.